ENTITY
Bioporto A/S

Bioporto A/S (BIOPOR DC)

10
Analysis
Health CareDenmark
Bioporto A/S develops and markets antibody-based products, including tests to diagnose human disease. The Company's developments include a test (NGAL) to diagnose and monitor acute kidney damage.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x